Selected publications
- Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence. Clinical Genitourinary Cancer. 2018 In Process GET IT
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy. Prostate Cancer and Prostatic Diseases. 2017 Academic Article GET IT
- External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study. Clinical Genitourinary Cancer. 2017 Academic Article GET IT
- Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. European Journal of Surgical Oncology. 2017 Academic Article GET IT
- Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer. Clinical Genitourinary Cancer. 2017 In Process GET IT
- Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy. Urologic Oncology: Seminars and Original Investigations. 2017 Academic Article GET IT
- Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer. 2017 Academic Article GET IT
- Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer. Clinical Genitourinary Cancer. 2017 Academic Article GET IT
- ABO blood group and rhesus factor are not associated with outcomes after radical cystectomy for non-metastatic urothelial carcinoma of the bladder. Anticancer Research. 2017 Academic Article GET IT
-
Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.
Urologic Oncology: Seminars and Original Investigations.
2017
Academic Article
GET IT
Times cited: 2 -
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force.
European Urology.
2017
Academic Article
GET IT
Times cited: 15 - Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. Journal of Surgical Oncology. 2017 Academic Article GET IT
- Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations. 2017 Academic Article GET IT
- Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World Journal of Urology. 2017 Academic Article GET IT
- Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer. Urologia Internationalis. 2017 Academic Article GET IT
-
Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
Urology.
2017
Academic Article
GET IT
Times cited: 1 - Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. 2016 Academic Article GET IT
- Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy. Clinical Genitourinary Cancer. 2016 Academic Article GET IT
- Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations. 2016 Academic Article GET IT
- Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study. World Journal of Urology. 2016 Academic Article GET IT
-
Prognostic significance of markers of systemic inflammatory response in patients with non–muscle-invasive bladder cancer.
Urologic Oncology: Seminars and Original Investigations.
2016
Academic Article
GET IT
Times cited: 5 - Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. Urologic Oncology: Seminars and Original Investigations. 2016 Academic Article GET IT
- Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU International. 2016 Academic Article GET IT
-
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.
Nature Reviews Urology.
2016
Review
GET IT
Times cited: 5 -
Urothelial cancer of the upper urinary tract: Emerging biomarkers and integrative models for risk stratification.
Minerva Urologica e Nefrologica.
2016
Report
Times cited: 7 -
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin.
BJU International.
2016
Academic Article
GET IT
Times cited: 13 -
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.
Clinical Genitourinary Cancer.
2016
Academic Article
GET IT
Times cited: 3 -
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).
World Journal of Urology.
2016
Academic Article
GET IT
Times cited: 2 -
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
World Journal of Urology.
2016
Academic Article
GET IT
Times cited: 9 -
The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.
Urologic Oncology: Seminars and Original Investigations.
2016
Academic Article
GET IT
Times cited: 2 -
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
World Journal of Urology.
2016
Academic Article
GET IT
Times cited: 2 -
Impact of stage migration and practice changes on high-risk prostate cancer: Results from patients treated with radical prostatectomy over the last two decades.
BJU International.
2016
Academic Article
GET IT
Times cited: 6 -
Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.
BJU International.
2015
Academic Article
GET IT
Times cited: 2 -
Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
European Urology.
2015
Review
GET IT
Times cited: 33 -
Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
European Urology.
2015
Academic Article
GET IT
Times cited: 67 -
Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
European Urology.
2015
Academic Article
GET IT
Times cited: 14 - There Are Cooler Ways to Die Than Smoking: Urologists of the World, Unite Against This Health Care Tragedy. European Urology Focus. 2015 Editorial Article GET IT
-
Positive surgical margins after radical prostatectomy: A systematic review and contemporary update.
European Urology.
2014
Review
GET IT
Times cited: 105 -
Early salvage radiotherapy following radical prostatectomy.
European Urology.
2014
Review
GET IT
Times cited: 75 -
High-risk prostate cancer: From definition to contemporary management.
European Urology.
2012
Review
GET IT
Times cited: 86 -
Erectile function rehabilitation in the radical prostatectomy patient.
Journal of Sexual Medicine.
2010
Conference Paper
GET IT
Times cited: 79 -
Pelvic Lymph Node Dissection in Prostate Cancer.
European Urology.
2009
Review
GET IT
Times cited: 300